up 85% today , what gives?!!, page-26

Thx for the insight gargar......but it would seem that you
are too emotionallly attached to this stock/company.

Perhaps you have been burnt...perhaps you have some personal vendetta against GTG.....perhaps u are the CEO who got fired ?????

Either way, u simply wont baffle us with yr BS.

If you want to query licence $$$, u only need to review recent presentations that included increased licence fees.

As for patents, I would prefer an ongoing suite of patents
being applied/granted all the time rather than the single patent that u refer to, and are clearly clinging on to.

(Your like the baby who cries because the 'red snakes' are gone - when there is still a big bowl of mixed lollies).

That said, unless u are a fly on the wall (more like a mosquito) in licence discussions, Im not sure how u can state that Merv has no involvement in licenses. You are simply wrong AGAIN.

How naive to suggest the 'no licence/no cost' lawyers are the sole reason of increased licences, and not due to any Merv involvement.

Perhaps u havent experienced too many lawyers in yr time, but whilst they may write some letters and draw up licence agreements, they are NO scientists - Who who do u think actually goes to these companies, discusses the relevant infringements etc and reaches a final deal ??????

Your comment re the last CEO is outreageous and wrong !!
He wasnt fired for trying to get rid of Merv from licencing...he was fired for trying to shutdown the licencing program altogether !!! (You may recall the same CEO was also the brainchild of that wonderful attempt to start charging and/or litigating on BRCA testing - when the
company had previously made a point to allow it in AUS).

Do you really blame them for removing a guy that was clearly doing major damage to GTG on all fronts. ???

As for Brevagen,, you may be a movie buff - but you are seemingly no guru re commercial opportunities.

Did u consider it may have been a victim from the GFC ?. I suspect u havent had much experience in the US or with funders such as venture capitalists etc, but in times like the GFC, they tend to get cold feet rather quickly and when they do (regardless of issues or problems), they usually dump the product for minimal $$ rather than hanging around to extract the highest $$.

Further, regardless of whether its a 'one of a kind' product, it IS verified, IS easily marketable and fits in perfectly to the expanding suite of cancer tests and therapies that GTG are focussing on - and that in itself has GLOBAL potential for anyone/anything to do with cancers (from R&D, doctors and right thru to patients).

But hey,, don't let me bore you anymore with all this stuff when you clearly have better things to do like watching videos !

As for the SP, watch and learn !!!







an issue from my researchon are no
seemingly relevant